Although it affects millions of patients with hypertension, primary aldosteronism is mistakenly considered “rare.”
Understanding of the disease remains fragmented, and it is seldom diagnosed and treated.
Although it affects millions of hypertensives, primary aldosteronism is mistakenly considered “rare.” Understanding of the disease remains fragmented, and it is seldom adequately diagnosed and treated.
Welcome to the Primary Aldosteronism Foundation
A Non-Profit Committed to Advancing Standards of Care for all Affected Patients
We are a patient initiative created to make accurate and timely diagnosis and treatment a reality for all affected patients, foster targeted research and innovation, and facilitate patient collaboration worldwide.
We help those who have, or suspect hyperaldosteronism, to navigate the road to accurate diagnosis, obtain adequate and effective treatment, stay abreast of relevant medical advances, and optimize their care.
We serve the primary aldosteronism community worldwide and are headquartered in the US state of Arizona.
Whether you or someone you know have high blood pressure that is long-standing and/or difficult to control, help us support the development of adequate responses to primary aldosteronism by signing the Foundation’s Open Letter.
We serve the primary aldosteronism community worldwide and are headquartered in the US state of Arizona.
Whether you or someone you know have hypertension that is long-standing and/or difficult to control, help us support the development of adequate responses to primary aldosteronism by signing the Foundation’s Open Letter.
medical centers worldwide.
diagnosis and treatment
